压力骨折中的生物疗法:当前的概念
George Jacob1, Kazunori Shimomura2, Norimasa Nakamura3
1Department of Orthopaedic Surgery, Lakeshore Hospital, Cochin, India.
概括
压力骨折,常见的过度使用伤害,对运动员来说是具有挑战性的. 虽然生物药物具有潜力,但它们对压力骨折的有效性需要更多的研究,风险因素评估是关键.
科学领域:
- 整形医生 整形医生 整形医生
- 运动医学 运动医学
- 骨的新陈代谢 骨的新陈代谢
背景情况:
- 压力骨折是影响运动员和军事人员的过度使用伤害.
- 危险因素包括营养缺乏和影响骨健康的荷尔蒙变异.
- 传统治疗侧重于休息,固定和补充.
研究的目的:
- 审查压力骨折的不断变化的管理.
- 调查生物疗法的临床前和临床证据.
- 评估生物药物在加速愈合和缩短恢复时间方面的潜力.
主要方法:
- 对压力骨折治疗的临床前和临床研究的文献综述.
- 分析当前和新兴的治疗策略,包括生物药物.
- 检查风险因素及其对骨周转的影响.
主要成果:
- 在压力骨折中使用生物疗法的证据有限,并且往往补充了手术固定.
- 大多数研究缺乏对照组,随机对照试验正在进行中.
- 营养和荷尔蒙因素对于压力骨折的发展至关重要.
结论:
- 生物疗法看起来很有前途,但需要进一步研究压力骨折管理.
- 解决营养和荷尔蒙失衡等个体风险因素至关重要.
- 需要精心设计的随机对照试验来确定生物制剂的临床益处.
相关概念视频
Fractures: Bone Repair
3.2K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
3.2K
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


